Case Studies Activ Surgical

Innovating a cutting-edge surgical tool

About Activ

SVB is excited to share the Activ Surgical success story, a medical device company pioneering collaborative surgery with intelligent scopes and robots that are able to see what humans cannot.

The bold idea

Peter Kim, M.D., knew it wouldn’t be easy to finance his company’s idea for improving digital surgery. In medtech — a challenging market where regulatory and reimbursement barriers frequently cause expensive delays — a new device must be truly groundbreaking to make it.

But Activ Surgical’s technology was too promising to ignore: a hyperspectral imaging module that can seamlessly interface with existing endoscopes, transforming them into super scopes. This technology has the potential to dramatically improve outcomes within the current practice of minimally invasive surgery, and perhaps, more importantly, it can form a foundation on which digital and robotic surgery can make their next leap forward. The challenge: Convincing a financial partner to see its potential.

The partnership

Both Bill Sideris, relationship manager, and Ethan Sivulich, a credit analyst, with Silicon Valley Bank’s Northeast medical device and healthtech practice team, understand the challenges facing companies in this space. They were impressed by the new technology’s potential and the Activ team’s transformational vision.

“There are plenty of promising companies developing specialized imaging or guidance modalities to improve outcomes in specific procedures,” Bill said. “But what was intriguing about Activ’s technology was its truly expansive potential to improve the entire field.”

Bill, Ethan and their SVB colleagues went to work.

We’ve relied on SVB as our banking partner for years, and we were very pleased with the runway capital solutions they provided to take Activ to the next level. SVB knows us, the industry and our business.

Todd Usen, Chief Executive Officer, Activ Surgical

The solution

In addition to supporting Activ from its earliest days as their banking partner, the team at SVB tailored a debt solution that scaled with the company’s progress. SVB initially provided the company with a $2.5 million term loan tranched to certain regulatory and clinical milestones, followed by an upsize to $4 million.

The impact

SVB’s debt capital provided the company with enough runway to complete its development milestones and close a very successful Series B raise. Activ is now well positioned to bring ActivSight™ into operating rooms across the country and take the next step in realizing the technology’s full potential.
Life Science and Healthcare
Discover how SVB supports life science and healthcare companies at all stages of growth.
Learn more

Healthcare Investments & Exits Report

Discover healthcare investments and exits in the latest edition.

Learn more

Insights to inspire you


Read insights and stories from industry experts to help as you work to accelerate your company’s growth.  
Case Study
Building primary care centric delivery care networks
Privia Health is building one of the largest primary care centric ambulatory care delivery networks in the rapidly changing U.S. healthcare ecosystem
Case Study
Improving healthcare, growing strong
Aledade, a healthtech company that is helping physicians across the country deliver better care for their patients. Read how Aledade accelerated their growth and expansion with SVB's customized financing solutions.
Report
Healthcare Investments & Exits
Healthcare venture fundraising almost doubled over the previous year, with phenomenal growth across sub-sectors: biopharma, health tech, dx/tools and device. Download our report for a deep dive into the current healthcare landscape and critical trends to watch.
Case Study
Working together to target cancer
Mythic, a biopharma company is pioneering new antibody-drug conjugates to safely treat cancer patients. Read the case study to learn how creative and flexible debt solutions from SVB extended the company’s cash runway without diluting equity.
Case Study
Pivoting for promise in psoriasis treatment
As with many startups, engaging the right partner to establish funding is critical to success and first to market advantage. Read how SVB's tailored approach positioned DICE to accelerate the development of its psoriasis therapeutics while extending the runway for subsequent financing.